WOODBURY, N.Y. — BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced the appointment of Dr. Auro Nair as the company’s Chief Executive Officer. Dr. Nair has served on BioIVT’s Board of Directors since June 2024. “Dr. Nair brings deep life sciences experience, a drive for success, […]

Fully defined, synthetic ECM designed to improve reproducibility and reduce lot-to-lot variability Supports standardization of scalable 3D stem cell and organoid workflows Synthetic alternative to traditional matrices, enabling consistent performance while aligning with regulatory and translational initiatives MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the […]

PALO ALTO, Calif. — Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced pluripotent stem (iPS) cells from NKT cells and has begun offering them for research use. NKT cells are immune cells known to possess characteristics […]

Collaboration enhances life science lab connectivity by integrating automated imaging and detection systems into research workflows SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high‑performance life science solutions and an operating company of Danaher Corporation (NYSE:DHR), today announced a new collaboration with Automata, the London‑based lab automation company developing fully integrated, AI‑ready platforms […]

Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant  Initiative expected to deliver approximately $3 million in cost savings in 2027 and $4 million in annual cost savings beginning in 2028 while improving throughput and execution HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today […]

Beltsville, MD, USA – REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL’s proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL’s StemRNA™ […]

Dr. Hailing Shi to apply 3D spatial multi-omics to decode RNA regulation in the human brain and neurodegenerative diseases BOSTON — Stellaromics, a pioneer in high-resolution 3D spatial biology, today announced the installation of its Pyxa™ 3D spatial multi-omics system at Emory University School of Medicine. Emory becomes the third beta program site following successful deployments […]

New platform integrates epigenetic and transcriptomic analysis in a unified workflow, addressing key challenges in single-cell multi-omics research. LONDON, UK – SeekGene, a biotechnology company specializing in single-cell technology platforms, announced the launch of its novel high-throughput single-cell DNA methylation and RNA multi-omics solution at the Festival of Genomics & BioData 2026. The solution aims to […]

Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. — iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek […]

Waters Corporation’s Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass. — Waters Corporation (NYSE: WAT) (the “Company” or “Waters”) today announced that, at the Company’s Special Meeting of Shareholders (the “Special Meeting”) held today, Waters […]